S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
New Trump Bombshell (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
New Trump Bombshell (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
New Trump Bombshell (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
New Trump Bombshell (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
New Trump Bombshell (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
New Trump Bombshell (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
S&P 500   5,026.61
DOW   38,671.69
QQQ   437.05
Israel's finance minister blasts Moody's downgrade of the the country's credit rating
New Trump Bombshell (Ad)
FMC stock just set a new ceiling higher, 50% higher indeed
Mardi Gras beads are creating a plastic disaster in New Orleans. Are there green alternatives?
New Trump Bombshell (Ad)
Super Bowl Live Updates | 49ers are Super Bowl favorites in 2025
Airbnb stock bulls just went all in before earnings
Obama’s 2024 Confession (Ad)
3 stocks set to benefit from record Valentine's Day spending
Recession risks are fading, business economists say, but political tensions pose threat to economy
NASDAQ:PETS

PetMed Express (PETS) Stock Price, News & Analysis

$5.98
+0.11 (+1.87%)
(As of 02/9/2024 08:56 PM ET)
Today's Range
$5.36
$6.24
50-Day Range
$5.87
$7.71
52-Week Range
$5.36
$20.35
Volume
798,700 shs
Average Volume
363,346 shs
Market Capitalization
$126.48 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
$13.25

PetMed Express MarketRank™ Stock Analysis

Analyst Rating
Hold
2.00 Rating Score
Upside/​Downside
121.6% Upside
$13.25 Price Target
Short Interest
Bearish
19.01% of Float Sold Short
Dividend Strength
N/A
Sustainability
N/A
News Sentiment
0.40mentions of PetMed Express in the last 14 days
Based on 8 Articles This Week
Insider Trading
N/A
Proj. Earnings Growth
900.00%
From $0.01 to $0.10 Per Share

Overall MarketRank

New Rank-Based ScoringMarketRank is calculated by averaging available category scores (with extra weight given to analysis and valuation), then ranking the company's weighted average against that of other companies.

2.23 out of 5 stars

Retail/Wholesale Sector

129th out of 209 stocks

Drug Stores & Proprietary Stores Industry

3rd out of 4 stocks


PETS stock logo

About PetMed Express Stock (NASDAQ:PETS)

PetMed Express, Inc., together with its subsidiaries, operates as a pet pharmacy in the United States. The company markets prescription and non-prescription pet medications, health products, and other supplies for dogs, cats, and horses. It offers non-prescription medications and supplies, such as flea and tick control products, bone and joint care products, vitamins, treats, nutritional supplements, hygiene products, and supplies; and prescription medications, including heartworm preventatives, flea and tick preventatives, arthritis, dermatitis, thyroid, diabetes, pain medications, heart/blood pressure, and other specialty medications, as well as generic substitutes. The company also sells food, beds, crates, stairs, and other pet supplies. It sells its products through its Internet website; mobile app; customer support center; and direct mail/print, which includes brochures and postcards, as well as television advertising under the 1-800-PetMeds, PetCare Rx, and PetMeds brands. The company was incorporated in 1996 and is headquartered in Delray Beach, Florida.

PETS Stock Price History

PETS Stock News Headlines

An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Q3 2023 Petmed Express Inc Earnings Call
A Preview Of PetMed Express's Earnings
PetMed Express (PETS) to Release Quarterly Earnings on Thursday
An Unusual Way to Invest in Gold
Most financial experts recommend including gold in your investment mix to protect against rising prices and keep wealth secure. Investors are discovering a little-known way to benefit from gold, which offers the chance to gain from higher gold prices and mining successes while avoiding the costs of operating mines.
Is Ant Spray Safe for Pets?
5 Best Dog Food Brands for Small Breeds
PetMed Express Appoints Leslie Campbell As Chairman
PetMeds® Announces new Chairman of the Board
My Mom's Pet Shop Was Blown to Pieces
3 Promising Stocks to Buy in the Booming Pet Tech Industry
PetMed Express: Another Tough Year
PetMed Express Inc PETS
See More Headlines
Receive PETS Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for PetMed Express and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
10/30/2023
Today
2/11/2024
Fiscal Year End
3/31/2024

Industry, Sector and Symbol

Industry
Drug stores & proprietary stores
Sub-Industry
Internet Retail
Current Symbol
NASDAQ:PETS
CUSIP
71638210
Employees
302
Year Founded
1996

Price Target and Rating

Average Stock Price Target
$13.25
High Stock Price Target
$20.00
Low Stock Price Target
$6.50
Potential Upside/Downside
+121.6%
Consensus Rating
Hold
Rating Score (0-4)
2.00
Research Coverage
2 Analysts

Profitability

Net Income
$230,000.00
Pretax Margin
-2.38%

Debt

Sales & Book Value

Annual Sales
$256.86 million
Cash Flow
$0.53 per share
Book Value
$5.87 per share

Miscellaneous

Free Float
20,386,000
Market Cap
$126.48 million
Optionable
Optionable
Beta
0.74

Social Links

Investing Strategies To Help Grow Your Retirement Income Cover

Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.

Get This Free Report

Key Executives

  • Mr. Mathew N. Hulett (Age 53)
    CEO, President & Director
    Comp: $534.12k
  • Ms. Christine Chambers (Age 46)
    CFO, Principal Financial Officer, Principal Accounting Officer, Treasurer & Secretary
    Comp: $305.4k
  • Mr. Mark Moseley
    Chief Technology & Information Officer
  • Mr. Daniel Job Pingree
    Chief Marketing Officer
  • Ms. Jacqueline Smith
    Vice President of People
  • Wendy Zalai
    Corporate Controller & Corporate Secretary














PETS Stock Analysis - Frequently Asked Questions

Should I buy or sell PetMed Express stock right now?

2 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for PetMed Express in the last twelve months. There are currently 1 sell rating and 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "hold" PETS shares. A hold rating indicates that analysts believe investors should maintain any existing positions they have in PETS, but not buy additional shares or sell existing shares.
View PETS analyst ratings
or view top-rated stocks.

What is PetMed Express' stock price target for 2024?

2 brokerages have issued 12 month target prices for PetMed Express' stock. Their PETS share price targets range from $6.50 to $20.00. On average, they predict the company's share price to reach $13.25 in the next twelve months. This suggests a possible upside of 121.6% from the stock's current price.
View analysts price targets for PETS
or view top-rated stocks among Wall Street analysts.

How have PETS shares performed in 2024?

PetMed Express' stock was trading at $7.56 at the start of the year. Since then, PETS stock has decreased by 20.9% and is now trading at $5.98.
View the best growth stocks for 2024 here
.

How were PetMed Express' earnings last quarter?

PetMed Express, Inc. (NASDAQ:PETS) posted its quarterly earnings data on Monday, October, 30th. The company reported $0.09 earnings per share for the quarter, missing the consensus estimate of $0.18 by $0.09. The firm earned $71 million during the quarter, compared to analysts' expectations of $77.13 million. PetMed Express had a negative net margin of 2.25% and a positive trailing twelve-month return on equity of 0.93%. During the same quarter in the prior year, the company earned $0.13 earnings per share.

How often does PetMed Express pay dividends? What is the dividend yield for PetMed Express?

PetMed Express announced a quarterly dividend on Monday, July 31st. Investors of record on Monday, August 14th will be paid a dividend of $0.30 per share on Friday, August 18th. This represents a $1.20 dividend on an annualized basis and a dividend yield of 20.07%. The ex-dividend date is Friday, August 11th.
Read our dividend analysis for PETS
.

What ETFs hold PetMed Express' stock?

ETFs with the largest weight of PetMed Express (NASDAQ:PETS) stock in their portfolio include Formidable ETF (FORH), Amplify Online Retail ETF (IBUY), Global SuperDividend US ETF (DIV) and ProShares Pet Care ETF (PAWZ).Global X E-Commerce ETF (EBIZ).

What guidance has PetMed Express issued on next quarter's earnings?

PetMed Express updated its third quarter 2024 earnings guidance on Thursday, February, 8th. The company provided earnings per share (EPS) guidance of for the period. The company issued revenue guidance of $65.3 million-$65.3 million, compared to the consensus revenue estimate of $68.0 million.

What is Mendo Akdag's approval rating as PetMed Express' CEO?

5 employees have rated PetMed Express Chief Executive Officer Mendo Akdag on Glassdoor.com. Mendo Akdag has an approval rating of 46% among the company's employees. This puts Mendo Akdag in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

What other stocks do shareholders of PetMed Express own?

Based on aggregate information from My MarketBeat watchlists, some companies that other PetMed Express investors own include Intel (INTC), NVIDIA (NVDA), AT&T (T), Cisco Systems (CSCO), Alibaba Group (BABA), Gilead Sciences (GILD), Advanced Micro Devices (AMD), Verizon Communications (VZ), Netflix (NFLX) and Micron Technology (MU).

Who are PetMed Express' major shareholders?

PetMed Express' stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (2.75%), Charles Schwab Investment Management Inc. (2.02%), Profit Investment Management LLC (0.86%), Trexquant Investment LP (0.54%), UBS Group AG (0.33%) and Formidable Asset Management LLC (0.31%). Insiders that own company stock include Bruce S Rosenbloom, Christine Chambers, Gian Fulgoni and Mathew N Hulett.
View institutional ownership trends
.

How do I buy shares of PetMed Express?

Shares of PETS stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

This page (NASDAQ:PETS) was last updated on 2/12/2024 by MarketBeat.com Staff

My Account -